BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9870100)

  • 21. Diagnostic value of AgNOR method in thyroid cytopathology: correlation with morphometric measurements.
    Solymosi T; Tóth V; Sápi Z; Bodó M; Gál I; Csanádi L
    Diagn Cytopathol; 1996 Mar; 14(2):140-4. PubMed ID: 8964170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Argyrophilic nucleolar organizer regions in breast cancer: prognostic significance.
    Kolár Z; Zábranský T; Mattler K; Zábranský E
    Cesk Patol; 1992 Sep; 28(4):193-200. PubMed ID: 1335841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphometry and digital AgNOR analysis in cytological imprints of benign, borderline and malignant serous ovarian tumours.
    Stemberger-Papić S; Stanković T; Vrdoljak-Mozetic D; Versa-Ostojić D; Krasević M; Stifter S; Audy-Jurković S
    Cytopathology; 2006 Dec; 17(6):382-9. PubMed ID: 17168922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
    Pich A; Chiusa L; Margaria E
    Cancer Detect Prev; 1995; 19(3):282-91. PubMed ID: 7750118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prognostic value of AgNORs in breast cancer].
    Aubele M; Auer G; Jütting U
    Zentralbl Pathol; 1994 Mar; 140(1):55-60. PubMed ID: 7515674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of AgNOR count in distinguishing benign from malignant mesothelial cells in pleural fluids.
    Colecchia M; Leopardi O
    Pathol Res Pract; 1992 Jun; 188(4-5):541-4. PubMed ID: 1409085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Silver-stained Nucleolar Organizer Regions (AgNOR)].
    Derenzini M; Trerè D
    Pathologica; 2001 Apr; 93(2):99-105. PubMed ID: 11428299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nucleolar organizer regions in aspirates of malignant lymphomas and benign disorders of the lymph nodes.
    Xu LZ; Wang LF
    Anal Quant Cytol Histol; 1992 Apr; 14(2):148-52. PubMed ID: 1590898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nucleolar organizer regions in pigmented skin lesions. Value in the differential diagnosis of Spitz nevi.
    González-Cámpora R; Armas-Padrón JR; Rios-Martín JJ; López-Garrido J; Gómez-Pascual A; Galera-Davidson H
    Anal Quant Cytol Histol; 1991 Feb; 13(1):16-22. PubMed ID: 1709022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Silver-stained nucleoli and nucleolar organizer region counts are of no prognostic value in thick cutaneous malignant melanoma.
    Howat AJ; Giri DD; Wright AL; Underwood JC
    J Pathol; 1988 Nov; 156(3):227-32. PubMed ID: 3204453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Location of nucleolar organizer regions (AgNORs) in the nuclei of astrocytic tumors.
    Pedal WP; Warzok RW; Hufnagl P; Roth K
    Clin Neuropathol; 1995; 14(1):55-61. PubMed ID: 7729083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A critical evaluation of AgNOR counting in benign naevi and malignant melanoma.
    Orrell JM; Evans AT; Grant A
    J Pathol; 1991 Mar; 163(3):239-44. PubMed ID: 1707452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell cycle-dependent AgNOR analysis in invasive breast cancer.
    Krüger S; Stahlhut M; Müller H
    Anal Quant Cytol Histol; 2000 Oct; 22(5):358-63. PubMed ID: 11064811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Silver-binding nucleolar organizer regions (AgNORs) in the normal epithelium of different parts of the digestive tract in rats.
    Zaczek M; Maciejowski J; Gil K; Szot W; Chłap Z
    Folia Histochem Cytobiol; 1994; 32(2):127-35. PubMed ID: 7958071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nucleolar organizer regions in melanocytic dysplasia and melanoma.
    Fallowfield ME; Dodson AR; Cook MG
    Histopathology; 1988 Jul; 13(1):95-9. PubMed ID: 3209193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nucleolar organizer regions in iris nevi and melanomas.
    Marcus DM; Mawn LA; Egan KM; Albert DM
    Am J Ophthalmol; 1992 Aug; 114(2):202-7. PubMed ID: 1642296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantity of AgNORs in gastric endocrine carcinoid tumours as a potential prognostic tool.
    Giuffrè G; Mormandi F; Barresi V; Bordi C; Tuccari G; Barresi G
    Eur J Histochem; 2006; 50(1):45-50. PubMed ID: 16584984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between intraepithelial neoplasia of the cervix and the size and number of nucleolar organizer regions.
    Egan M; Freeth M; Crocker J
    Gynecol Oncol; 1990 Jan; 36(1):30-3. PubMed ID: 2295449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morphometric analysis of AgNORs in the lymph node lesions.
    Arora B; Jain R; Kumar S; Rekhi B; Arora H; Arora DR
    Adv Clin Path; 2002 Apr; 6(2):95-9. PubMed ID: 19753731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Counting the nucleolar organizer region-associated proteins is a prognostic clue of malignant melanoma.
    Gambini C; Casazza S; Borgiani L; Canepa M; Rovida S; Rongioletti F; Rebora A
    Arch Dermatol; 1992 Apr; 128(4):487-90. PubMed ID: 1580655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.